Nanomedicine formulations include, among others, Doxil® and Myocet® (liposomal doxorubicin) and Abraxane® (albumin nanoparticle of paclitaxel), indicated to treat advanced-stage breast cancer [27,28]. This evidence concerns the gene ALB and breast carcinoma.